4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-005544
Chief Executive Officer sold 9,879 shares at $5.67 ($56,009)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2021-01-19 | Sale | −9,879 | $5.67 | $56,009 | 13,529 | D |
| Open-market sales · 9,879 sh · avg $5.67 · $56,009 | |||||||
Loading xslF345X03/tm213569-1_4seq1.xml…